Berikutnya

Putar otomatis

The Impact and Long-Term Potential of Olaratumab in Soft Tissue Sarcoma

2 Tampilan • 07/18/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

Symantha Melemed, PhD, global product team lead, Oncology Business Unit, Eli Lilly & Company, discusses the impact of the FDA approval of olaratumab (Lartruvo) and its long-term potential in the field of sarcoma.

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis